Himax Technologies
HIMX
14.09
-0.76
-5.12%
Himax Technologies
US · HIMX
#2608 by market cap
Listed 2006
14.09
-0.76
-5.12%
Live - 5344 symbols - heartbeat 71s ago
· 2026-10-08 07:00
Pre-market
13.74
-2.48%
After-hours
14.05
-0.28%
Overnight
13.93
-1.14%
- Market cap
- 2.46B
- P/E (TTM)i
- 66.78
- P/Bi
- 2.73
- EPSi
- 0.26
- Div yieldi
- 1.79%
- 52W posi
- 41%
Reader sentiment
Are you bullish or bearish on HIMX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.18, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -8.23% YoY
Margins
- Gross margin
- 30.57%
- Operating margin
- 5.30%
- Net margin
- 5.28%
Key ratios & quality
- Enterprise valuei
- 2.77B
- Altman Z-Scorei
- 3.18
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 723.61M | 671.84M | 887.28M | 1.55B | 1.20B | 945.43M | 906.80M | 832.17M |
| Gross profit | 168.92M | 137.92M | 220.78M | 748.58M | 487.11M | 263.50M | 276.20M | 254.36M |
| Selling & admin expenses | 42.20M | 41.30M | 40.59M | 52.36M | 53.96M | 48.89M | 47.65M | 49.11M |
| Research & development | 123.04M | 114.86M | 122.27M | 151.39M | 175.56M | 171.39M | 160.33M | 161.13M |
| Operating profit | 3.39M | -18.31M | 57.93M | 545.02M | 257.59M | 43.21M | 68.22M | 44.13M |
| Pretax profit | 7.02M | -15.77M | 56.87M | 544.59M | 276.57M | 44.39M | 77.34M | 54.87M |
| Tax | 994.00K | 416.00K | 11.71M | 110.66M | 41.10M | -5.03M | -2.44M | 9.59M |
| Net profit | 6.03M | -16.18M | 45.16M | 433.94M | 235.47M | 49.42M | 79.77M | 45.28M |
| Basic EPS | 0 | 0 | 0 | 3 | 1 | 0 | 0 | 0 |
| Diluted EPS | 0.04 | -0.08 | 0.28 | 2.50 | 1.36 | 0.28 | 0.46 | 0.26 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 215.13M | 214.80M | 199.16M | 203.08M | 199.01M | 227.37M |
| Gross profit | 65.55M | 67.01M | 60.10M | 61.70M | 60.45M | 75.24M |
| Selling & admin expenses | 10.76M | 11.36M | 13.77M | 13.23M | 12.11M | 12.75M |
| Research & development | 34.99M | 37.54M | 46.95M | 41.65M | 38.18M | 37.92M |
| Operating profit | 19.81M | 18.11M | -618.00K | 6.83M | 10.16M | 24.56M |
| Pretax profit | 24.02M | 22.06M | 348.00K | 8.43M | 10.55M | 25.00M |
| Tax | 3.84M | 5.05M | -1.00M | 1.70M | 2.11M | 4.65M |
| Net profit | 20.18M | 17.01M | 1.35M | 6.73M | 8.44M | 20.36M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.11 | 0.10 | 0.01 | 0.07 | 0.05 | 0.11 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 654.42M | 604.67M | 694.41M | 1.19B | 1.34B | 1.20B | 1.17B | 1.27B |
| Cash & ST investments | 117.67M | 112.10M | 201.42M | 364.38M | 229.90M | 206.38M | 224.57M | 286.22M |
| Inventory | 162.56M | 143.77M | 108.71M | 198.60M | 370.93M | 217.31M | 158.75M | 152.68M |
| Total assets | 836.68M | 818.48M | 909.82M | 1.60B | 1.70B | 1.64B | 1.64B | 1.74B |
| Total current liabilities | 391.16M | 380.89M | 352.24M | 601.23M | 694.00M | 708.80M | 706.63M | 799.51M |
| Short-term debt | 184.00M | 222.77M | 113.07M | 162.00M | 379.52M | 463.64M | 513.41M | 576.09M |
| Long-term debt | -- | -- | 52.50M | 46.50M | 40.50M | 34.50M | 28.50M | 22.50M |
| Total liabilities | 394,391,000.00 | 387,237,000.00 | 424,619,000.00 | 731,212,000.00 | 807,937,000.00 | 779,702,000.00 | 743,194,000.00 | 832,881,000.00 |
| Total equity | 442.29M | 431.24M | 485.20M | 871.98M | 893.82M | 863.70M | 896.33M | 902.14M |
| Retained earnings | 244.16M | 230.54M | 272.94M | 660.30M | 679.13M | 640.45M | 664.60M | 643.59M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.17B | 1.23B | 1.24B | 1.27B | 1.26B | 1.29B |
| Cash & ST investments | 280.98M | 332.75M | 278.20M | 286.22M | 287.61M | 298.74M |
| Inventory | 129.87M | 134.57M | 137.42M | 152.68M | 151.67M | 151.47M |
| Total assets | 1.64B | 1.71B | 1.69B | 1.74B | 1.73B | 1.77B |
| Total current liabilities | 684.32M | 798.42M | 775.82M | 799.51M | 775.69M | 835.78M |
| Short-term debt | 510.30M | 510.72M | 575.19M | 576.09M | 574.20M | 574.20M |
| Long-term debt | 27.00M | 25.50M | 24.00M | 22.50M | 21.00M | 19.50M |
| Total liabilities | 719,362,000.00 | 836,847,000.00 | 812,022,000.00 | 832,881,000.00 | 805,944,000.00 | 864,722,000.00 |
| Total equity | 916.12M | 871.29M | 882.56M | 902.14M | 922.94M | 909.45M |
| Retained earnings | 684.59M | 636.54M | 637.61M | 643.59M | 651.58M | 625.80M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.01M | 7.66M | 102.61M | 388.28M | 82.91M | 152.84M | 115.98M | 140.03M |
| Depreciation & amortization | 20.33M | 24.40M | 23.60M | 21.34M | 21.34M | 20.32M | 22.35M | 22.55M |
| Free cash flow | -46.59M | -38.42M | 96.74M | 380.25M | 70.78M | 129.35M | 102.77M | 119.51M |
| Dividends paid | -17.21M | 0 | -4.00K | -47.42M | -217.87M | -83.87M | -50.90M | -65.15M |
| Stock buybacks / issuance | -- | -- | -- | 0 | 487.00K | 916.00K | -2.93M | -3.81M |
| Ending cash balance | 106.44M | 101.06M | 184.94M | 336.02M | 221.58M | 191.75M | 218.15M | 257.50M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 56.05M | 60.47M | 6.70M | 16.81M | 4.01M | 17.54M |
| Depreciation & amortization | 5.16M | 5.28M | 5.39M | 6.73M | 5.94M | 5.91M |
| Free cash flow | 50.77M | 55.88M | 55.00K | 12.80M | 1.05M | 13.03M |
| Dividends paid | -- | -442.00K | -64.71M | 0 | -- | 0 |
| Stock buybacks / issuance | 0 | -3.00M | 158.00K | -969.00K | 0 | 0 |
| Ending cash balance | 275.45M | 304.68M | 257.09M | 257.50M | 259.69M | 271.30M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 1.90 | -3.10 | 10.32 | 64.73 | 26.89 | 5.79 | 9.13 | 4.93 |
| ROA %i | 1.05 | -1.65 | 5.45 | 34.77 | 14.34 | 3.03 | 4.86 | 2.60 |
| ROIC %i | 1.22 | -2.08 | 7.06 | 50.70 | 19.68 | 3.62 | 5.41 | 2.65 |
| 5-year avg ROE %i | 7.82 | 4.32 | 5.28 | 15.97 | 20.15 | 20.93 | 23.37 | 22.29 |
| EBIT margin %i | 1.14 | -2.00 | 6.60 | 35.27 | 23.25 | 5.34 | 8.97 | 7.01 |
| FCF / sales %i | -- | -- | 10.90 | 24.58 | 5.89 | 13.68 | 11.33 | 14.36 |
| Current ratioi | 1.67 | 1.59 | 1.97 | 1.98 | 1.93 | 1.69 | 1.65 | 1.58 |
| Quick ratioi | 0.79 | 0.73 | 1.27 | 1.29 | 0.71 | 0.63 | 0.65 | 0.61 |
| Debt / assetsi | 21.99 | 27.22 | 18.20 | 13.01 | 24.68 | 30.31 | 33.05 | 34.50 |
| LT debt / equityi | -- | -- | 10.93 | 5.35 | 4.54 | 4.03 | 3.20 | 2.52 |
| Interest coveragei | 6.70 | -5.78 | 34.36 | 508.07 | 100.38 | 8.30 | 20.27 | 16.72 |
| Revenue CAGR (3Y) %i | 1.51 | -5.77 | 9.00 | 28.83 | 21.38 | 2.14 | -16.31 | -11.52 |
| Net income CAGR (3Y) %i | -30.20 | -- | 19.41 | 270.81 | -- | 2.40 | -43.27 | -42.98 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | 10.17 | -35.35 | 19.08 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 9.59 | 8.61 | 7.15 | 4.93 | 3.50 | 4.00 |
| ROA %i | 5.33 | 4.38 | 3.74 | 2.60 | 1.90 | 2.03 |
| ROIC %i | 5.64 | 5.01 | 3.95 | 2.65 | 1.83 | 2.11 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 10.17 | 9.35 | 8.75 | 7.01 | 5.49 | 5.75 |
| FCF / sales %i | 10.89 | 14.97 | 16.03 | 14.36 | 8.55 | 3.25 |
| Current ratioi | 1.71 | 1.54 | 1.60 | 1.58 | 1.62 | 1.55 |
| Quick ratioi | 0.73 | 0.69 | 0.62 | 0.61 | 0.62 | 0.62 |
| Debt / assetsi | 32.85 | 31.39 | 35.36 | 34.50 | 34.43 | 33.46 |
| LT debt / equityi | 2.97 | 2.95 | 2.74 | 2.52 | 2.30 | 2.17 |
| Interest coveragei | 23.85 | 22.16 | 20.97 | 16.72 | 13.19 | 14.27 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Driver Integrated Circuit (IC) is the largest reported line at 80.01% of revenue, across 2 reported segments.
- The next-largest line, Non-driver products, is a distant second at 19.99% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Driver Integrated Circuit (IC)80.01%
Non-driver products19.99%
Region
China73.76%
Taiwan14.72%
Korea5.96%
America2.56%
Japan1.80%
Others0.61%
Mexico0.58%
Quote time 2026-10-08 07:00:30 · For reference only, not investment advice and not tailored to your situation.